Cdc42, Rac1, and Rac2 Display Distinct Patterns of Activation During Phagocytosis
Overview
Molecular Biology
Authors
Affiliations
The small G proteins Cdc42, Rac1, and Rac2 regulate the rearrangements of actin and membrane necessary for Fcgamma receptor-mediated phagocytosis by macrophages. Activated, GTP-bound Cdc42, Rac1, and Rac2 bind to the p21-binding domain (PBD) of PAK1, and this interaction provided a basis for microscopic methods to localize activation of these G proteins inside cells. Fluorescence resonance energy transfer-based stoichiometry of fluorescent chimeras of actin, PBD, Cdc42, Rac1, and Rac2 was used to quantify G protein activation relative to actin movements during phagocytosis of IgG-opsonized erythrocytes. The activation dynamics of endogenous G proteins, localized using yellow fluorescent protein-labeled PBD, was restricted to phagocytic cups, with a prominent spike of activation over an actin-poor region at the base of the cup. Refinements of fluorescence resonance energy transfer stoichiometry allowed calculation of the fractions of activated GTPases in forming phagosomes. Cdc42 activation was restricted to the leading margin of the cell, whereas Rac1 was active throughout the phagocytic cup. During phagosome closure, activation of Rac1 and Rac2 increased uniformly and transiently in the actin-poor region of phagosomal membrane. These distinct roles for Cdc42, Rac1, and Rac2 in the component activities of phagocytosis indicate mechanisms by which their differential regulation coordinates rearrangements of actin and membranes.
CD47 prevents Rac-mediated phagocytosis through Vav1 dephosphorylation.
Miller W, Mishra A, Sheedy C, Bond A, Gardner B, Montell D bioRxiv. 2025; .
PMID: 39990418 PMC: 11844498. DOI: 10.1101/2025.02.11.637707.
Ziane-Chaouche L, Raffo-Romero A, Hajjaji N, Kobeissy F, Pinheiro D, Aboulouard S Cell Death Dis. 2024; 15(12):879.
PMID: 39632807 PMC: 11618602. DOI: 10.1038/s41419-024-07267-4.
Targeted protein degradation: advances in drug discovery and clinical practice.
Zhong G, Chang X, Xie W, Zhou X Signal Transduct Target Ther. 2024; 9(1):308.
PMID: 39500878 PMC: 11539257. DOI: 10.1038/s41392-024-02004-x.
Silencing of SIRPα enhances the antitumor efficacy of CAR-M in solid tumors.
Zhang H, Huo Y, Zheng W, Li P, Li H, Zhang L Cell Mol Immunol. 2024; 21(11):1335-1349.
PMID: 39379603 PMC: 11527885. DOI: 10.1038/s41423-024-01220-3.
Zhang Y, Xia N, Hu Y, Zhu W, Yang C, Su J Sci China Life Sci. 2024; 67(12):2713-2729.
PMID: 39279006 DOI: 10.1007/s11427-023-2625-7.